Position in NKTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,716,722
+$1,395,446 QoQ
Shares Held
2,373,400
-5.9% QoQ
Ownership
3.31%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#7
of 136 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names. NKTX ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,231,026 | $13,921,602 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
184,937 | $10,582,095 | |
| 3 | RCKT |
Rocket Pharmaceuticals, Inc.
|
2,480,468 | $8,483,200 | |
| 4 | NKTX |
Nkarta, Inc.
This page
|
2,373,400 | $6,716,722 | |
| 5 | NVAX |
Novavax Inc
|
577,464 | $5,439,710 | |
| 6 | PLRX |
Pliant Therapeutics, Inc.
|
1,938,747 | $2,210,171 | |
| 7 | VNDA |
Vanda Pharmaceuticals Inc.
|
221,286 | $1,354,270 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
|
25,600 | $767,488 |
All Filings in NKTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,716,722 | 2,373,400 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,321,276 | 2,521,932 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,711,824 | 2,546,932 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,079,783 | 1,970,910 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,628,397 | 1,583,372 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,496,133 | 813,116 | Shares | Sole | 2025-05-08 | |
| 2023-09-30 | $326,978 | 235,236 | Shares | Sole | 2023-11-07 | |
| No filing history on record for this holder in this stock. | ||||||